M
Matthew L. Boulton
Researcher at University of Michigan
Publications - 169
Citations - 6290
Matthew L. Boulton is an academic researcher from University of Michigan. The author has contributed to research in topics: Vaccination & Public health. The author has an hindex of 30, co-authored 158 publications receiving 5487 citations. Previous affiliations of Matthew L. Boulton include Michigan Department of Community Health & Council of State and Territorial Epidemiologists.
Papers
More filters
Journal ArticleDOI
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.
Soju Chang,Dawn M. Sievert,Jeffrey C. Hageman,Matthew L. Boulton,Fred C. Tenover,Frances P. Downes,Sandip Shah,James T. Rudrik,Guy R. Pupp,William J. Brown,Denise M. Cardo,Scott K. Fridkin +11 more
TL;DR: Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers and carried the vanA resistance gene, which may have come from the vancomycius-resistant Enterococcus faecalis that was also isolated from the patient.
Journal Article
Staphylococcus aureus Resistant to Vancomycin—United States, 2002
Dawn M. Sievert,Matthew L. Boulton,G. Stoltman,David W. Johnson,Mary Grace Stobierski,William J. Brown,W Hafeez,T Lundstrom,E Flanagan,R. Johnson,James E. Mitchell,S Chang +11 more
Journal ArticleDOI
Effects of smoking during pregnancy. Five meta-analyses.
TL;DR: Smoking during pregnancy is a significant and preventable factor affecting ectopic pregnancy, placental abruption, placenta previa, and PPROM and the findings of smoking's apparently protective effect on pre-eclampsia should be balanced with these harmful effects.
Journal ArticleDOI
Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines
Arnold S. Monto,Suzanne E. Ohmit,Joshua G. Petrie,Emileigh Johnson,Rachel Truscon,Esther Teich,Judy R. Rotthoff,Matthew L. Boulton,John C. Victor +8 more
TL;DR: In the 2007-2008 season, the inactivated vaccine was efficacious in preventing laboratory-confirmed symptomatic influenza A (predominately H3N2) in healthy adults and the live attenuated vaccine also prevented influenza illnesses but was less efficacious.
Journal ArticleDOI
Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines
Suzanne E. Ohmit,John C. Victor,Judy R. Rotthoff,Esther Teich,Rachel Truscon,Laura L. Baum,Bhavya Rangarajan,Duane W. Newton,Matthew L. Boulton,Arnold S. Monto +9 more
TL;DR: In the 2004-2005 season, in which most circulating viruses were dissimilar to those included in the vaccine, the inactivated vaccine was efficacious in preventing laboratory-confirmed symptomatic illnesses from influenza in healthy adults and the live attenuated vaccine also prevented influenza illnesses but was less efficacious.